Muraglitazar
id:
muraglitazar-303-18412282
title:
Muraglitazar
text:
Muraglitazar is a dual peroxisome proliferator-activated receptor agonist with affinity to PPARα and PPARγ. The drug had completed phase III clinical trials, however in May 2006 Bristol-Myers Squibb announced that it had discontinued further development. Data on muraglitazar is relatively sparse due to the brief introduction and subsequent abandonment of this agent. One double-blind randomized clinical trial comparing muraglitazar and pioglitazone found that the effects of the former were favour
brand slug:
wiki
category slug:
encyclopedia
description:
Chemical compound
original url:
https://en.wikipedia.org/wiki/Muraglitazar
date created:
date modified:
2023-10-04T19:50:49Z
main entity:
{"identifier":"Q6937233","url":"https://www.wikidata.org/entity/Q6937233"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/1/1d/Muraglitazar.svg","width":512,"height":181}
fields total:
13
integrity:
15